IJMSC: Toward Digital Self-monitoring of Multiple Sclerosis: Investigating First Experiences, Needs, and Wishes of People with MS

Release Date: December 1, 2019
Valid for Credit Through: December 1, 2020

Target Audience:
The target audience for this activity is physicians, physician assistants, nursing professionals, and other health care providers involved in the management of patients with multiple sclerosis (MS).

Learning Objectives:
1) Indicate potential benefits and challenges regarding the use of digital self-monitoring tools, particularly smartphone apps and activity trackers, by people with MS.
2) Identify needs and wishes of people with MS regarding the use of digital self-monitoring tools.

In support of improving patient care, this activity has been planned and implemented by the Consortium of Multiple Sclerosis Centers (CMSC) and Delaware Media Group. The CMSC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician Credit
The CMSC designates this journal-based activity for a maximum of .75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurse Credit
The CMSC designates this enduring material for .75 contact hour (none in the area of pharmacology).

Francois Bethoux, MD, Editor in Chief of the International Journal of MS Care (IJMSC), has served as physician planner for this activity. He has disclosed relationships with Springer Publishing (royalty); Qr8 (receipt of intellectual property rights/patent holder); Abide Therapeutics, GW Pharma (consulting fee); Biogen (speakers’ bureau); and Adamas Pharmaceuticals (contracted research).

Laurie Scudder, DNP, NP, has served as reviewer for this activity. She has disclosed no relevant financial relationships.

Karine Wendrich, MSc, has disclosed no relevant financial relationships.

Pim van Oirschot, MSc, has disclosed a relationship with Orikami/MS sherpa BV (salary).

Marijn Bart Martens, PhD, has disclosed no relevant financial relationships.

Marco Heerings, MANP, has disclosed no relevant financial relationships.

Peter Joseph Jongen, PhD, has disclosed relationships with Bayer (educational/consultancy activities) and MS sherpa BV (consulting fee).

Lotte Krabbenborg, PhD, has disclosed no relevant financial relationships.

One peer reviewer has disclosed relationships with Genentech (consulting fee, contracted research) and Novartis (contracted research). The other peer reviewers for IJMSC have disclosed no relevant financial relationships.

The staff at IJMSC, CMSC, and Delaware Media Group who are in a position to influence content have disclosed no relevant financial relationships.

Note: Financial relationships for some authors may have changed in the interval between listing these disclosures and publication of the article.

In order to receive CME/CNE credit, participants must:
1) Review the continuing education information, including learning objectives and author disclosures.
2) Study the educational content.
3) Complete the post-test and evaluation.

Statements of Credit are awarded upon successful completion of the post-test with a passing score of >70% and the evaluation.

There is no fee to participate in this activity.

Disclosure of Unlabeled Use:
This educational activity may contain discussion of published and/or investigational uses of agents that are not approved by the FDA. CMSC and Delaware Media Group do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of CMSC or Delaware Media Group.

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any medications, diagnostic procedures, or treatments discussed in this publication should not be used by clinicians or other health-care professionals without first evaluating their patients’ conditions, considering possible contraindications or risks, reviewing any applicable manufacturer’s product information, and comparing any therapeutic approach with the recommendations of other authorities.

​Instructions for Completing the Post Test and Claiming Credit

  1. To complete the post-test, evaluation and claim credit, please click on the To Claim Credit button below or go to:
  2. Log in with your user name and password*, or create a new account.
  3. Select the Enduring Materials tab, then select this activity from the listing and follow the instructions to complete the activity and receive your credit.

*If you forgot your username or password, click on Forgot password. Your login credentials will be emailed to you.

Contact Information

If you have questions about this CME/CNE activity, please contact the CMSC at [email protected] or 201-487-1050.

From the Faculty of Science, Institute for Science in Society (KW, LK), and Department of Neuroinformatics, Donders Institute for Brain, Cognition and Behaviour (MBM), Radboud University, Nijmegen, the Netherlands; MS sherpa BV, Nijmegen, the Netherlands (PvO); National MS Foundation, Rotterdam, the Netherlands (MH [now at Radboud University Medical Center]); MS4 Research Institute, Nijmegen, the Netherlands (PJJ); and Department of Health Sciences, Community and Occupational Medicine, University Medical Centre Groningen, Groningen, the Netherlands (PJJ). Correspondence: Karine Wendrich, MSc, Heyendaalseweg 135, 6525 AJ Nijmegen, the Netherlands; e-mail: [email protected].